DexCom's stock narrative has shifted as analysts lower their fair value estimate from $98.40 to $84.96, marking a significant downward revision in the price target. This adjustment is primarily driven ...
Palo Alto Networks stock has seen its consensus analyst price target edge up, rising from $217.67 to $219.75 in recent weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback